{{Rsnum
|rsid=1160312
|Gene=C19orf26
|Chromosome=20
|position=22069865
|Orientation=plus
|GMAF=0.3926
|Gene_s=C19orf26
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 31.0 | 47.8 | 21.2
| HCB | 8.8 | 42.3 | 48.9
| JPT | 8.0 | 36.3 | 55.8
| YRI | 5.4 | 35.4 | 59.2
| ASW | 7.0 | 43.9 | 49.1
| CHB | 8.8 | 42.3 | 48.9
| CHD | 15.6 | 38.5 | 45.9
| GIH | 16.8 | 53.5 | 29.7
| LWK | 4.6 | 35.8 | 59.6
| MEX | 8.6 | 43.1 | 48.3
| MKK | 3.2 | 42.3 | 54.5
| TSI | 18.6 | 47.1 | 34.3
| HapMapRevision=28
}}[http://www.nature.com/ng/journal/vaop/ncurrent/abs/ng.255.html nature] [[Baldness]] OR = 1.60, P = 1.1 times 10-14). see also [[gs122]]

The risk allele is assumed to be [[rs1160312]](A). Note that a haplotype consisting of [[rs201571]](T) - [[rs6036025]](G) has a perfect correlation (r2 = 1) with [[rs1160312]](A), at least in the Caucasian population studied.

{{PMID Auto GWAS
|PMID=18849991
|Trait=Male-pattern baldness
|Title=Male-pattern baldness susceptibility locus at 20p11
|RiskAllele=A
|Pval=1E-14
|OR=1.60
|ORtxt=[1.42-1.80] (males)
|OA=1
}}

{{omim
|desc=ALOPECIA, ANDROGENETIC, 3; AGA3
|id=612421
|rsnum=1160312
}}

{{PharmGKB
|RSID=rs1160312
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:18849991; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=Male-pattern baldness susceptibility locus at 20p11. (Initial Sample Size: 578 cases, 547 controls; Replication Sample Size: 1,351 cases, 2,485 controls); (Region: 20p11.22; Reported Gene: PAX1; Risk Allele: rs1160312-A) This variant is associated with Male-pattern baldness.
|Drugs=
|Drug Classes=
|Diseases=Alopecia
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740875
}}

{{PharmGKB
|RSID=rs1160312
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:18849991; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Male-pattern baldness susceptibility locus at 20p11. (Initial Sample Size: 578 cases, 547 controls; Replication Sample Size: 1,351 cases, 2,485 controls); (Region: 20p11.22; Reported Gene(s): PAX1; Risk Allele: rs1160312-A); (p-value= 0.00000000000001).This variant is associated with Male-pattern baldness.
|Drugs=
|Drug Classes=
|Diseases=Alopecia
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740799
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1160312
|overall_frequency_n=72
|overall_frequency_d=128
|overall_frequency=0.5625
|n_genomes=40
|n_genomes_annotated=0
|n_haplomes=58
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{PMID Auto
|PMID=24386074
|Title=Androgenic Alopecia Is Associated with Less Dietary Soy, Higher Blood Vanadium and rs1160312 1 Polymorphism in Taiwanese Communities
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}